Publicaciones en las que colabora con José A. Obeso Inchausti (8)

2022

  1. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

    Neurobiology of Disease, Vol. 167

2015

  1. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: A longitudinal in-vivo study

    Neurobiology of Disease, Vol. 77, pp. 165-172

2012

  1. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study

    Neurobiology of Disease, Vol. 48, Núm. 1, pp. 79-91

2011

  1. Statistical parametric maps of 18F-FDG PET and 3-D autoradiography in the rat brain: A cross-validation study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, Núm. 12, pp. 2228-2237

2010

  1. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463

2009

  1. New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification

    NeuroImage, Vol. 47, Núm. 2, pp. 533-539

2008

  1. Síntesis rápida y simplificada de 11C-(+)-α- dihidrotetrabenazina para su utilización como radioligando PET de los transportadores vesiculares de monoaminas

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 1, pp. 13-21

  2. Utilización de la11C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 2, pp. 103-111